Latest Cash Runway News

Audeara Limited has secured a $1.22 million R&D tax incentive refund for FY25, strengthening its financial position by repaying debt and retaining non-dilutive funding to fuel ongoing product development.

Epsilon Healthcare reports a strong rebound with a 73% revenue increase in the June quarter, driven by contract manufacturing and new pharmacy operations. The company is emerging from restructuring with renewed financial strength and growth prospects.

FBR Limited unveiled its new DST-enabled Mantis welding robot targeting heavy fabrication sectors while completing key milestones on its Hadrian bricklaying technology and securing a $22 million financing package.

Greenvale Energy’s maiden drilling at the Oasis Uranium Project delivers multiple high-grade uranium intercepts, while the company expands its tenure in the Northern Territory’s prolific Pine Creek region.

Genmin Limited has made significant progress on its Baniaka iron ore project in Gabon, with PowerChina submitting competitive engineering and construction proposals and the company securing A$15 million in director-related loans during the quarter.

NT Minerals Limited reported a net cash outflow of A$590,000 for Q3 2025 but bolstered its liquidity with A$1.07 million from investing activities, leaving it with over two quarters of funding runway.

Challenger Gold Limited reported a solid cash position of A$27.7 million for Q3 2025, backed by strong financing activities and a funding runway exceeding five quarters. The company’s strategic financing arrangements underpin its ongoing exploration ambitions.

Battery Age Minerals has advanced its exploration with maiden drilling at Austria’s Bleiberg zinc-germanium project and secured approvals for gold-silver drilling in Argentina, while expanding its North American footprint with a new germanium-gallium asset in Utah.

APC Minerals reported encouraging gold intersections from its Laverton Downs drilling program while navigating a tight cash position and ongoing asset acquisition efforts.

Chimeric Therapeutics has progressed its CHM CDH17 and CHM CORE-NK clinical trials with promising safety and efficacy signals, while securing a key manufacturing partnership and appointing a renowned haematologist to its board. However, the company faces a pressing cash runway challenge.

Equinox Resources reports promising rare earth results in Brazil while facing a legal challenge over Aboriginal heritage sites at its Hamersley Iron Ore Project in Western Australia. The company also divests a Canadian asset and prepares for leadership changes.

Hexima Limited reports a steady cash balance of AUD 1.44 million with a modest quarterly operating cash burn, while exploring strategic options including a potential capital return to shareholders.